R. Aeba et al., Modified ultrafiltration improves carbon dioxide removal after cardiopulmonary bypass in infants, ARTIF ORGAN, 24(4), 2000, pp. 300-304
Little is known about the role of modified ultrafiltration in ameliorating
the adverse effects of the cardiopulmonary bypass on pulmonary function in
infants. Twenty-nine nonrandomized consecutive infants (<12 months of age)
who underwent unrestrictive ventricular septal defect closure between 1995
and 1998 were included in this study. Down's syndrome was associated in 9 p
atients. The actual ventilator settings were highly homogeneous among all p
atients and each time point in the study. Fourteen infants received modifie
d ultrafiltration after the discontinuation of cardiopulmonary bypass. Fift
een untreated patients served as the control group. Correlates of cardiac a
nd pulmonary functions for both groups were compared. The arterial carbon d
ioxide tension in the experimental group was significantly lower than in th
e control group from 20 to 240 min after bypass. Arterial oxygenation and p
ulmonary arterial pressure were similar in the 2 groups. Modified ultrafilt
ration improves carbon dioxide removal after cardiopulmonary bypass in infa
nts. This may potentially convey a beneficial impact on hemodynamics.